Aralez Pharma completes sale of Vimovo royalties and Canadian ops; s...

12/31/18

Aralez Pharma completes sale of Vimovo royalties and Canadian ops; shares up 50%  Seeking Alpha

Aralez Pharmaceuticals (OTCPK:ARLZQ +50%) has completed the sale of its VIMOVO royalties and Canadian operations to Nuvo Pharmaceuticals for $110M.

[more]